Abstract
Aquaporin (AQP) water channel proteins are responsible for osmotically driven water transport across cell membranes of mammalian tissues, lower animals and plants. Recently, the cDNAs encoding ten mammalian AQPs with widely different tissue expression patterns have been cloned. This article reviews the recent progress in molecular cloning, gene organization, chromosomal localization and mutations of human AQPs. Sequence and genomic structure analyses indicate that the AQP gene family contains at least three subgroup. AQPs 0, 1, 2, 4, 5 and 6 have 40-50 percent amino acid homology and their genes contain 4 exons. AQPs 3, 7 and 9 belong to distinct subfamily that contains 6 exons and functions as transporters of small neutral solutes as well as water. AQP8 belongs to the third subgroup with unique exon-intron boundaries. Mutations in AQP2 cause human nephrogenic diabetes insipidus (NDI). The understanding of AQP genetics is important in studying the pathogenesis of diseases related AQP disorders a nd finding new targets for therapy.
Keywords: Aquaporin Gene Family, AQP, Human aquaporins, Human AQP9, Aquaporin Gene Cluster, CDNA sequences
Current Genomics
Title: The Human Aquaporin Gene Family
Volume: 1 Issue: 1
Author(s): Baoxue Yang
Affiliation:
Keywords: Aquaporin Gene Family, AQP, Human aquaporins, Human AQP9, Aquaporin Gene Cluster, CDNA sequences
Abstract: Aquaporin (AQP) water channel proteins are responsible for osmotically driven water transport across cell membranes of mammalian tissues, lower animals and plants. Recently, the cDNAs encoding ten mammalian AQPs with widely different tissue expression patterns have been cloned. This article reviews the recent progress in molecular cloning, gene organization, chromosomal localization and mutations of human AQPs. Sequence and genomic structure analyses indicate that the AQP gene family contains at least three subgroup. AQPs 0, 1, 2, 4, 5 and 6 have 40-50 percent amino acid homology and their genes contain 4 exons. AQPs 3, 7 and 9 belong to distinct subfamily that contains 6 exons and functions as transporters of small neutral solutes as well as water. AQP8 belongs to the third subgroup with unique exon-intron boundaries. Mutations in AQP2 cause human nephrogenic diabetes insipidus (NDI). The understanding of AQP genetics is important in studying the pathogenesis of diseases related AQP disorders a nd finding new targets for therapy.
Export Options
About this article
Cite this article as:
Yang Baoxue, The Human Aquaporin Gene Family, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351832
DOI https://dx.doi.org/10.2174/1389202003351832 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene Therapy for Lysosomal Storage Diseases: Progress, Challenges and Future Prospects
Current Pharmaceutical Design Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review
Current Cardiology Reviews Vasopressin in Liver Disease – Should We Turn On or Off?
Current Clinical Pharmacology Selective Modulation of Aβ42 Production in Alzheimers Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
Current Pharmaceutical Design Gender Differences in Ischemic Heart Disease
Recent Patents on Cardiovascular Drug Discovery Forensic Toxicology and Pharmacogenomics: Hype or Hope For Higher Standards in Forensic Medicine?
Current Pharmacogenomics and Personalized Medicine Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Current Pharmaceutical Design Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Induced Adaptive Resistance to Nitrooxidative Stress in the CNS: Therapeutic Implications
Central Nervous System Agents in Medicinal Chemistry Ca<sup>2+</sup> Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
Current Vascular Pharmacology Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Current Medicinal Chemistry Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms
Current Cardiology Reviews The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Evaluation of a New <sup>99m</sup>Tc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection
Anti-Cancer Agents in Medicinal Chemistry Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis
Current Pharmaceutical Design Delivery of Curcumin and Medicinal Effects of the Copper(II)-Curcumin Complexes
Current Pharmaceutical Design